Autopsy report · NCT03696485

Study to Assess the Safety and Efficacy of an IT Administration of SCM-010 in SPMS

“Due to sponsor decision”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 1, Phase 2

Sponsor

Stem Cell Medicine Ltd.

Sponsor type

Industry

Conditions

Secondary Progressive Multiple Sclerosis (SPMS)

Interventions

SCM-010

Participants

0

Sites

1

Countries

Israel

Trials that died the same way

• Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations
  “Due to the sponsor circumstances and external reasons” (87% match in meaning)
• OTL38 Injection (OTL38) for Intra-Operative Imaging of Folate Receptor Positive Ovarian Cancer
  “Due to sponsor request” (87% match in meaning)
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
  “Sponsor Decision” (86% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.